Found: 35
Select item for more details and to access through your institution.
Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 1100, doi. 10.3390/ijms18051100
- By:
- Publication type:
- Article
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231151845
- By:
- Publication type:
- Article
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 208, doi. 10.1186/1476-4598-9-208
- By:
- Publication type:
- Article
Spheroids from adipose‐derived stem cells exhibit an miRNA profile of highly undifferentiated cells.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 11, p. 8778, doi. 10.1002/jcp.26785
- By:
- Publication type:
- Article
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211049779
- By:
- Publication type:
- Article
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211049779
- By:
- Publication type:
- Article
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975326
- By:
- Publication type:
- Article
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184344
- By:
- Publication type:
- Article
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2118, doi. 10.3390/cancers13092118
- By:
- Publication type:
- Article
Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 993, doi. 10.3390/cancers13050993
- By:
- Publication type:
- Article
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3396, doi. 10.3390/cancers12113396
- By:
- Publication type:
- Article
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2415, doi. 10.3390/cancers12092415
- By:
- Publication type:
- Article
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1158, doi. 10.3390/cancers12051158
- By:
- Publication type:
- Article
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10911-5
- By:
- Publication type:
- Article
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 140, n. 3, p. 505, doi. 10.1007/s10549-013-2649-0
- By:
- Publication type:
- Article
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 113, n. 1, p. 67, doi. 10.1007/s10549-008-9906-7
- By:
- Publication type:
- Article
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.827822
- By:
- Publication type:
- Article
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682445
- By:
- Publication type:
- Article
Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?
- Published in:
- Analytical Cellular Pathology: Cellular Oncology, 2015, v. 2015, p. 1, doi. 10.1155/2015/690916
- By:
- Publication type:
- Article
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919848872
- By:
- Publication type:
- Article
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919848872
- By:
- Publication type:
- Article
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 9, p. 2186, doi. 10.1111/j.1582-4934.2012.01527.x
- By:
- Publication type:
- Article
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1414343
- By:
- Publication type:
- Article
The Interplay between Metabolism, PPAR Signaling Pathway, and Cancer.
- Published in:
- PPAR Research, 2017, p. 1, doi. 10.1155/2017/1830626
- By:
- Publication type:
- Article
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway.
- Published in:
- PPAR Research, 2017, p. 1, doi. 10.1155/2017/8187235
- By:
- Publication type:
- Article
Comment on: Survey of cervical cancer survivors regarding quality of life and sexual function.
- Published in:
- 2017
- By:
- Publication type:
- Letter
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis.
- Published in:
- Journal of Assisted Reproduction & Genetics, 2014, v. 31, n. 10, p. 1277, doi. 10.1007/s10815-014-0305-1
- By:
- Publication type:
- Article
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 6, p. 1368, doi. 10.1002/jcp.24295
- By:
- Publication type:
- Article
Genetic and molecular characterization of the human Osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 6, p. 1189, doi. 10.1002/jcp.24272
- By:
- Publication type:
- Article
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations.
- Published in:
- Oncology, 2013, v. 85, n. 5, p. 306, doi. 10.1159/000354737
- By:
- Publication type:
- Article
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.946319
- By:
- Publication type:
- Article
WHAT ARE THE MULTIGENIC FINGERPRINT HALLMARKS IN TRIPLE-NEGATIVE BREAST CANCER?
- Published in:
- Journal of Biological Research / Bollettino della Società Italiana di Biologia Sperimentale, 2021, v. 94, p. 43
- By:
- Publication type:
- Article
CIRCULATING IMMUNE-CHECKPOINTS AND LYMPHOCYTE MICRORNAs IN RENAL CELL CARCINOMA AS A NOVEL BIOMARKERS OF IMMUNOTHERAPY RESPONSE.
- Published in:
- Journal of Biological Research / Bollettino della Società Italiana di Biologia Sperimentale, 2021, v. 94, p. 40
- By:
- Publication type:
- Article
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/746858
- By:
- Publication type:
- Article